The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.The sixth seminar in the series, The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets, was held October 21, 2021 from 3:30 p.m. - 5:30 p.m. ET.
Co-chairs:
Faculty:
Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).
The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets Seminar; Presenter: Byoung S. Kwon, PhD - Eutilex; Date: October 21, 202100:15:03
The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets Seminar; Presenter: Michael Milone, MD, PhD - University of Pennsylvania; Date: October 21, 202100:21:32
The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets Seminar; Presenter: Christian Klein, PhD - Roche Innovation Center Zurich; Date: October 21, 202100:19:28
The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets Seminar; Presenter: Ignacio Melero, MD, PhD - CIMA, Clinica Universidad de Narvarro; Date: October 21, 202100:22:47
The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets Seminar; Presenter: Ignacio Melero, MD, PhD - CIMA, Clinica Universidad de Narvarro; Carl H June, MD - University of Pennsylvania; Byoung S. Kwon - Eutilex; Michael Milone, M, PhD - University of Pennsylvania; Christian Klein, PhD - Roche Innovation Center Zurich; Date: October 21, 202100:31:06
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us